NASDAQ:AIMT Aimmune Therapeutics (AIMT) Earnings Date, Estimates & Call Transcripts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$34.49▼$34.4950-Day Range$34.30▼$34.5952-Week Range$10.09▼$37.00VolumeN/AAverage Volume1.71 million shsMarket Capitalization$2.26 billionP/E RatioN/ADividend YieldN/APrice TargetN/A EarningsProfileFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Aimmune Therapeutics Analyst ForecastsCurrent Year EPS Consensus Estimate:($4.35) EPSNext Year EPS Consensus Estimate: ($2.93) EPS Aimmune Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript Aimmune Therapeutics Earnings - Frequently Asked Questions How much profit does Aimmune Therapeutics generate each year? Aimmune Therapeutics (NASDAQ:AIMT) has a recorded net income of -$248.50 million. AIMT has generated -$3.97 earnings per share over the last four quarters. What is Aimmune Therapeutics's EPS forecast for next year? Aimmune Therapeutics's earnings are expected to grow from ($4.35) per share to ($2.93) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SDGR Earnings Date AMPH Earnings Date HRMY Earnings Date VTYX Earnings Date GLPG Earnings Date XENE Earnings Date ZLAB Earnings Date NUVL Earnings Date MORF Earnings Date MRVI Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CarMax Slides On Earnings Disappointment, Time To Celebrate?5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 EarningsDoes Ciena's Earnings Beat Signal New Networking Boom Ahead?The 5 Most Upgraded Stocks From Q2 Earnings Reporting SeasonNordstrom: 3 Reasons the Pre-Earnings Dip Is an OpportunityWhat Ross Stores Earnings Say About The Saver Shopping Economy3 Ways To Trade, Trade Desk Stock Post Earnings This page (NASDAQ:AIMT) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimmune Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.